drugset
drugset / Trial / NCT02811939

Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone: Sub-Study I

NCT02811939 ↗

Phase 1 Completed 13 enrolled Yale University
RandomizedCrossoverQuadruple-blindBasic science

Summary

The overall purpose of this study is to examine the effect of Pregnenolone (PREG) on the acute psychosis-like and cognitive effects of Delta-9-Tetrahydrocannabinol (THC). This will be tested by pretreating healthy individuals with PREG, and then assessing their responses to Dronabinol (THC).

Timeline

Start
2016-04-07
Primary completion
2017-06-09
Completion
2017-06-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Dronabinol Other / unclassified 20 mg Oral
Subject Pregnenolone Other / unclassified 1.79 mg/kg Other

Indications

No indication recorded.